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Reply to L.J. da Silva
To the Editor: Dr. da Silva’s letter raises several
important points. My article, however, was never
intended to be comprehensive. The choice of
which emerging infectious diseases to include
was difficult, especially in a country where many
endemic infections continue at a high prevalence
and others, thought to be controlled, are
reemerging.
As Dr. da Silva states, many reports (in
Portuguese and English) discuss infectious
diseases in Brazil; however, this information is
rarely current. The information about measles in
my article is a case in point. At the time of my
article, an outbreak causing national concern was
occurring in Brazil; it has since been controlled. A
further problem is that the most detailed and
reliable studies are generally of only a regional or
local nature, for example, the recent excellent
report by Merchan-Hamann (1) on the situation
of endemic diseases in north and northeastern
Brazil and other references cited by Dr. da Silva.
To obtain current information at the national
level and provide numerical data rather than
merely discuss current trends, I focused on
notifiable diseases.
As Dr. da Silva states, schistosomiasis has
continued to decrease both in the number of cases
and associated illness. Onchocerciasis has been
restricted to a small focus in northern Brazil for
many years, and a recent report of a new focus in
the state of Goias has yet to be confirmed. In my
opinion, neither infection could be considered
emerging. An important helminthiasis that
perhaps should be mentioned is Bancroftian
filariasis with a main focus in Recife and minor
foci in Belem and Alagoas. Because of traditional
and novel control strategies, the number of cases
is declining in all foci.
The information I used about hepatitis is
confirmed by the National Reference Center on
Viral Hepatitis of the Ministry of Health. Febrile
illnesses in the Amazon are the great enigma and
probably provide the cover for many new diseases
that may still emerge. For example, only
approximately 20% of blood slides taken from
suspected malaria patients in the Amazon are
confirmed as positive, which leaves at least one
million cases of febrile illness per year
undiagnosed. I am unaware of any data that show
Mayaro and Oropouche viruses as the most
common cause of these illnesses. Dr. da Silva’s
letter provides useful additional information on
bacterial diseases, antimicrobial resistance, and
a number of low-prevalence diseases that may in
time prove to be important emerging infections.
Hooman Momen
Instituto Oswaldo Cruz, FIOCRUZ,
Rio de Janeiro, Brazil
Reference:
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A Brief Update on Rabbit
Hemorrhagic Disease Virus
To the Editor: We read with interest the paper by
A. Smith et al. (Emerg Infect Dis 1998; 1:13-20)
on calicivirus emergence from ocean reservoirs.
Our attention was drawn particularly to the data
and comments regarding rabbit hemorrhagic
disease (RHD), a recently emerged and devastat-
ing disease of just one rabbit species, Oryctolagus
cuniculus. We have been involved in RHD
research and diagnosis since 1989. Like D.
Gregg’s laboratory at the Foreign Animal
Diseases, U.S. Department of Agriculture,
Greenport, USA, our laboratory at the Istituto
Zooprofilatico Sperimentale della Lombardia e
dell’Emilia, Brescia, Italy, was in 1991 desig-
nated a Reference Laboratory for RHD by the
International Office of Epizootics (OIE), Paris,
France. Although other aspects of the article by
Dr. Smith and colleagues appear unclear (e.g.,
the fact that feline calicivirus is classified among
human pathogens like Norwalk virus), we will
confine our comments to a few main points
concerning RHD virus (RHDV).
Is RHDV a calicivirus or a parvovirus? RHD
is caused by a calicivirus (1-3). The articles cited
by Dr. Smith date back to 1991 and are part of a
book review promoted and edited by OIE (4). This
landmark review includes papers from China and
the United States supporting the parvovirus
hypothesis and papers from Europe concluding
that RHDV is a calicivirus. A retrospective
reading of those articles may explain the reasons
for the misinterpretation of some results.
However, this occurred in 1991 and, after 7 years,
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calicivirus. Actually, RHDV is one of the best
characterized caliciviruses, and the publication
of its full genome sequence in 1991 was the first of
a Caliciviridae member (5).
Diagnostic tools have been developed by our
and other laboratories (3,4,6). Thanks also to
specific monoclonal antibodies produced towards
RHDV and European brown hare syndrome virus
(EBHSV) by our colleague E. Brocchi, we
standardized different enzyme-linked
immunosorbent assays (ELISAs) for the diagno-
sis of related diseases (4,6-8). In particular, we
developed five different ELISAs for serology that
allow the detection of antibodies specific for
RHDV or EBHSV or that are cross-reactive. In
addition, we can define the antibody response in
rabbits and hares in terms of isotype-involved
immunoglobulin M (IgM), IgA, and IgG (9). Today
the main difficulty is the qualitative distinction
between RHDV and rabbit calicivirus (RCV, a
recently identified nonpathogenic calicivirus)
antibodies because of the close antigenic profiles
of these viruses (6). Finally, RHDV- and EBHSV-
specific polymerase chain reaction has been
developed in at least five laboratories besides
ours. We have sent these reagents and/or
diagnostic methods to at least 19 laboratories
outside Italy, including Australia, New Zealand,
and the United States.
Does RHDV infect humans? This question
has arisen together with the prospect of using
RHDV as a biologic control agent in countries like
Australia and New Zealand, when they were free
of RHDV. In Europe, where the disease naturally
occurred and quickly spread, no particular
control on human health was planned. In Italy
only, between 1987 and 1990, hundreds of
millions of rabbits died of RHD in regions where
the average density of humans is very high. As a
consequence of the use of the vaccine since 1991,
the incidence of RHD among breeding rabbits
decreased drastically and quickly. Nevertheless,
the disease is still endemic, mainly in small farms
and among wild rabbits. EBHS also is endemic in
wild hares, and hunters are highly exposed to the
virus since hares are their main target. However,
neither in humans nor in animal species other
than rabbits and hares have any diseases similar
to RHD ever been reported. In relation to the
likelihood of mild or inapparent infections, we
used 100 human sera randomly selected from
blood donors to carry out a preliminary
standardization of an RHD-ELISA that has been
periodically used to control the sera of the RHD
laboratory staff. Very recently, we tested nine
sera from laboratory personnel exposed to
RHDV; again no positive result was noted by
RHD-ELISA. These findings have  limited
epidemiologic value, but considering the high
level of exposure of part of the sample, it is
evident that RHDV infection in humans is
unlikely to be the rule.
Lorenzo Capucci and Antonio Lavazza
Istituto Zooprofilattico Sperimentale della
Lombardia e dell’Emilia, Brescia, Italy
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Rabbit Hemorrhagic Disease
To the Editor: The recent article on calicivirus by
Smith et al. (1) is misleading in its use of the
study concerning human health aspects of rabbit
hemorrhagic disease (RHD) by Mead et al. (2).